These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10695481)

  • 21. Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies.
    Cai X
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):789-800. PubMed ID: 17173496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis.
    Vogt F; Zernecke A; Beckner M; Krott N; Bosserhoff AK; Hoffmann R; Zandvoort MA; Jahnke T; Kelm M; Weber C; Blindt R
    J Am Coll Cardiol; 2008 Jul; 52(4):302-11. PubMed ID: 18634987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental models that mimic the differentiation and dedifferentiation of vascular cells.
    Pauly RR; Passaniti A; Crow M; Kinsella JL; Papadopoulos N; Monticone R; Lakatta EG; Martin GR
    Circulation; 1992 Dec; 86(6 Suppl):III68-73. PubMed ID: 1330366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of smooth muscle cell proliferation and phenotype by integrin signaling through focal adhesion kinase.
    Morla AO; Mogford JE
    Biochem Biophys Res Commun; 2000 May; 272(1):298-302. PubMed ID: 10872843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The extracellular matrix dynamically regulates smooth muscle cell responsiveness to PDGF.
    Raines EW; Koyama H; Carragher NO
    Ann N Y Acad Sci; 2000 May; 902():39-51; discussion 51-2. PubMed ID: 10865824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells.
    Weiser MC; Grieshaber NA; Schwartz PE; Majack RA
    Mol Biol Cell; 1997 Jun; 8(6):999-1011. PubMed ID: 9201711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smooth muscle cell diversity and the extracellular matrix in a rat model of restenosis.
    Majesky MW; Dong XR; Topouzis S
    P R Health Sci J; 1996 Sep; 15(3):187-91. PubMed ID: 8994283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis.
    Assoian RK; Marcantonio EE
    J Clin Invest; 1996 Dec; 98(11):2436-9. PubMed ID: 8958203
    [No Abstract]   [Full Text] [Related]  

  • 30. Vascular smooth muscle cells : isolation, culture, and characterization.
    Siow RC; Pearson JD
    Methods Mol Med; 2001; 46():237-45. PubMed ID: 21340924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinogen and atherosclerosis.
    Smith EB
    Wien Klin Wochenschr; 1993; 105(15):417-24. PubMed ID: 8379153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis.
    Assoian RK; Marcantonio EE
    J Clin Invest; 1997 Dec; 100(11 Suppl):S15-8. PubMed ID: 9413395
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells--a potential mechanism for the weakening and rupture of atherosclerotic plaques.
    Leskinen MJ; Kovanen PT; Lindstedt KA
    Biochem Pharmacol; 2003 Oct; 66(8):1493-8. PubMed ID: 14555226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramural coronary artery disease in swine with naturally occurring hypertrophic cardiomyopathy.
    Dai KS; Chu R; Chiu YT; Lin JH; Liu SK; Hwang JP; Yang PC; Huang TY; Mao SJ
    J Submicrosc Cytol Pathol; 1997 Oct; 29(4):511-9. PubMed ID: 9397588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease.
    Raines EW
    Int J Exp Pathol; 2000 Jun; 81(3):173-82. PubMed ID: 10971738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cinematographic analysis of vascular smooth muscle cell interactions with extracellular matrix.
    Absher M; Baldor L
    In Vitro Cell Dev Biol; 1991 Jan; 27(1):25-30. PubMed ID: 2013550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury.
    Thyberg J
    Histol Histopathol; 1998 Jul; 13(3):871-91. PubMed ID: 9690143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of smooth muscle cells in the initiation and early progression of atherosclerosis.
    Doran AC; Meller N; McNamara CA
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):812-9. PubMed ID: 18276911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Integrins in Modulating Smooth Muscle Cell Plasticity and Vascular Remodeling: From Expression to Therapeutic Implications.
    Jain M; Chauhan AK
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial cell influences on vascular smooth muscle phenotype.
    Campbell JH; Campbell GR
    Annu Rev Physiol; 1986; 48():295-306. PubMed ID: 3518616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.